Show simple item record

dc.contributor.authorAboy, Mateoen
dc.contributor.authorLiddicoat, Johnen
dc.contributor.authorLiddell, Kathleenen
dc.contributor.authorJordan, Matthewen
dc.contributor.authorCrespo, Cristinaen
dc.date.accessioned2019-10-29T00:31:10Z
dc.date.available2019-10-29T00:31:10Z
dc.date.issued2017-09en
dc.identifier.issn1087-0156
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/298135
dc.description.abstractExamining the types of claim amendments that have transformed isolated gene claims from patent-ineligible into eligible subject matter provides clarity into the threshold of eligibility for gene-related patents.
dc.format.mediumPrinten
dc.languageengen
dc.publisherSpringer Nature
dc.rightsAll rights reserved
dc.rights.uri
dc.titleAfter Myriad, what makes a gene patent claim 'markedly different' from nature?en
dc.typeArticle
prism.endingPage825
prism.issueIdentifier9en
prism.publicationDate2017en
prism.publicationNameNature biotechnologyen
prism.startingPage820
prism.volume35en
dc.identifier.doi10.17863/CAM.45192
dcterms.dateAccepted2017-08-15en
rioxxterms.versionofrecord10.1038/nbt.3953en
rioxxterms.versionAM
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserveden
rioxxterms.licenseref.startdate2017-09en
dc.contributor.orcidAboy, Mateo [0000-0002-5168-4321]
dc.contributor.orcidLiddicoat, Johnathon [0000-0001-7370-3936]
dc.identifier.eissn1546-1696
rioxxterms.typeJournal Article/Reviewen
rioxxterms.freetoread.startdate2018-03-30


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record